CG Oncology, Inc. Common stock
CG Oncology, Inc. Common stock (CGON) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · CGON · as of Jun 8, 2026
Activity summary
Buy transactions
1
P-Purchase only
Sell transactions
23
12 Months
Buy/Sell ratio
0.04
Buy/Sell (by trades)
Overall sentiment
CG Oncology, Inc. Common stock insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
CGON insider buying and selling by quarter
CGON insider selling · CGON insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · CGON ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
CGON executive sell shares · CGON board member insider trading · CGON insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 4, 2026 | POST LEONARD E Director | Option | 1,000 | $600 | Form 4 |
| Jun 4, 2026 | POST LEONARD E Director | Sale | 1,000 | $55K | Form 4 |
| Apr 17, 2026 | Mulay James Director | Option | 15,600 | $571K | Form 4 |
| Apr 17, 2026 | Mulay James Director | Sale | 15,600 | $1.14M⚡ | Form 4 |
| Mar 16, 2026 | Mulay James Director | Option | 1,310 | $16K | Form 4 |
| Mar 16, 2026 | Mulay James Director | Option | 654 | $2K | Form 4 |
| Mar 16, 2026 | Mulay James Director | Sale | 1,310 | $83K | Form 4 |
| Mar 12, 2026 | Kuan Arthur CEO · Director | Option | 64,612 | $111K | Form 4 |
| Mar 12, 2026 | Kuan Arthur CEO · Director | Other | 1,847 | $111K | Form 4 |
| Mar 4, 2026 | Kuan Arthur CEO · Director | Option | 102,871 | $177K | Form 4 |
| Mar 4, 2026 | Kuan Arthur CEO · Director | Other | 2,871 | $177K | Form 4 |
| Jan 9, 2026 | Mulay James Director | Option | 10,491 | $132K | Form 4 |
| Jan 9, 2026 | Mulay James Director | Option | 654 | $2K | Form 4 |
| Jan 9, 2026 | Mulay James Director | Sale | 654 | $29K | Form 4 |
| Jan 9, 2026 | Mulay James Director | Sale | 10,491 | $556K | Form 4 |
| Nov 17, 2025 | POST LEONARD E Director | Option | 1,000 | $600 | Form 4 |
| Nov 17, 2025 | POST LEONARD E Director | Sale | 1,000 | $41K | Form 4 |
| Oct 13, 2025 | POST LEONARD E Director | Option | 1,000 | $600 | Form 4 |
| Oct 13, 2025 | POST LEONARD E Director | Sale | 1,000 | $43K | Form 4 |
| Oct 9, 2025 | Mulay James Director | Option | 5,903 | $22K | Form 4 |
| Oct 9, 2025 | Mulay James Director | Sale | 5,903 | $260K | Form 4 |
| Sep 30, 2025 | POST LEONARD E Director | Option | 5,000 | $3K | Form 4 |
| Sep 30, 2025 | POST LEONARD E Director | Sale | 5,000 | $200K | Form 4 |
| Sep 29, 2025 | Mulay James Director | Option | 12,755 | $23K | Form 4 |
| Sep 29, 2025 | Mulay James Director | Sale | 12,755 | $500K | Form 4 |
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About CGON insider trading
CGON insider trades
CG Oncology, Inc. Common stock (CGON) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Mulay James (Director), POST LEONARD E (Director), Kuan Arthur (CEO · Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. CGON insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For CG Oncology, Inc. Common stock's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
CGON insider trading · 5 questionsThe insiders of CG Oncology, Inc. Common stock (CGON) include executives and directors such as Mulay James (Director), POST LEONARD E (Director), Kuan Arthur (CEO · Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026